Safety, Tolerability, and Effectiveness of Duodenal Mucosal RF Vapor Ablation for Insulin Elimination in Type-2 Diabetes

计划入组 16 人 · 首次发布于 2024 年 10 月 23 日

Study of Duodenal Mucosal RF Vapor Ablation in Subjects With Type-2 Diabetes Mellitus

计划入组 40 人 · 首次发布于 2023 年 6 月 5 日

RF Vapor Ablation Retreatment of Duodenal Mucosa in Non-responders With Type-2 Diabetes Mellitus

计划入组 12 人 · 首次发布于 2024 年 12 月 9 日

Filgrastim biosimilar (Institute of Medical Biology Chinese Academy of Medical Sciences)

Medical Cannabis

Medical air

AQUA PHARMACEUTICALS

India

Aqua Vitoe Laboratories

India

Foshan Aqua Gel Biotech Co.,Ltd.

China

Aqua Medical Receives FDA IDE Approval for Breakthrough Endoscopic Type 2 Diabetes Treatment

Aqua Medical Advances PIMA Procedure for Type 2 Diabetes with First West Coast Patient and New CEO

Neurophet Receives Third FDA 510(k) Clearance for AI-Powered Alzheimer's Imaging Analysis Software